Effect of mastitis on some hematological and biochemical parameters of Red Sokoto goats.

AIM: This research project investigates the effect of mastitis on some hematological and biochemical parameters of Red Sokoto goats (RSGs). MATERIALS AND METHODS: In this investigation, 16 clinically and subclinically diagnosed mastitic and 20 non-mastitic RSGs, within Sokoto metropolis, were sampled. Blood samples were collected both in ethylenediaminetetraacetic acid and anticoagulant free sample bottles for hematology and biochemical analysis, respectively. RESULTS: A statistical analysis of the results revealed no significant difference in all the hematological parameters analyzed for both the mastitic and non-mastitic goats except mean corpuscular hemoglobin where significant difference (p<0.05) was observed. Similarly, no significant difference was recorded in the serum biochemistry except for the increase in total protein (p<0.001), globulin (p<0.05), and alanine aminotransferase activity (p<0.05). CONCLUSION: This finding is a pointer to the fact that mastitis could be regarded as a localized problem affecting the udder without serious systemic or metabolic involvement in RSGs.

Antigenic potential of a recombinant polyvalent DNA vaccine against pathogenic leptospiral infection.

Leptospirosis is a serious epidemic disease caused by pathogenic Leptospira species. The disease is endemic in most tropical and sub-tropical regions of the world. Currently, there is no effective polyvalent vaccine for prevention against most of the circulating serovars. Moreover, development of an efficient leptospiral vaccine capable of stimulating cross-protective immune responses against a wide range of serovars remains a daunting challenge. This, in part, is associated with the extensive diversity and variation of leptospiral serovars from region to region. In this study, a multi-epitope DNA vaccine encoding highly immunogenic epitopes from LipL32 and LipL41 was designed using in-silico approach. The DNA encoding antigenic epitopes was constructed from conserved pathogenic Leptospira genes (LipL32 and LipL41). Immunization of golden Syrian hamsters with the multi-epitope chimeric DNA vaccine resulted in the production of both agglutinating and neutralizing antibodies as evidence by MAT and in-vitro growth inhibition tests respectively. The antibodies produced reacted against eight different serovars and significantly reduced renal colonization following in vivo challenge. The vaccine was also able to significantly reduce renal colonization which is a very important factor responsible for persistence of leptospires among susceptible and reservoir animal hosts. In conclusion, the leptospiral multi-epitope chimeric DNA vaccine can serve as a potentially effective and safe vaccine against infection with different pathogenic leptospiral serovars.